Publications

Explore the collection of published articles spanning biotechnology research and applications.

South Asian Medical Cohorts Reveal Strong Founder Effects And High Rates Of Homozygosity

Nature communications, Vol. 14, Issue 1, Pages 3377, 2023
PMID: 37291107
The benefits of large-scale genetic studies for healthcare of the populations studied are well documented, but these genetic studies have traditionally ignored people from some parts of the world, such as South Asia. Here we describe whole genome sequence (WGS) data from 4806 individuals recruited from the healthcare delivery systems of Pakistan, India and Bangladesh, combined with WGS from 927 individuals from isolated South Asian populations.

Filaggrin gene polymorphisms in Indian children with atopic dermatitis: A cross-sectional multicentre study

Indian journal of dermatology, venereology and leprology, Pages 1-9, 2023
PMID: 37067103
Filaggrin (FLG) gene encoding the protein filaggrin plays an important role in barrier function of the skin and its alteration is a predisposing factor for atopic dermatitis. FLG gene variants result in absent or decreased filaggrin protein. Worldwide, the prevalence of FLG variants ranges from 14 to 56%. FLG null variants are distinct in each population.

Large Region of Homozygous (ROH) Identified in Indian Patients with Autosomal Recessive Limb-Girdle Muscular Dystrophy with p.Thr182Pro Variant in SGCB Gene

Human Mutation, Vol. 2023, Article Number: 362273, 2023
Sarcoglycanopathies are autosomal recessive limb-girdle muscular dystrophies (LGMDs) caused by mutations in genes encoding the α, β, γ, and δ proteins that stabilize the muscle cell sarcolemma. Clinically, they present as progressive proximal muscle weakness with childhood onset. Muscle biopsy confirms dystrophic changes and sarcoglycan protein deficiencies. This study summarized 1,046 LGMD patients diagnosed via targeted sequencing. The most frequent phenotypes were LGMDR1 (19.7%), LGMDR4 (19.0%), LGMDR2 (17.5%), and MMD1 (14.5%). Variants in CAPN3, SGCB, and DYSF were found in over 10% of patients, with SGCB p.Thr182Pro being the most common (12.5%), homozygous in 97.9%. Genotyping of 68 patients with this variant revealed a ~1 Mb region of homozygosity, suggesting a shared founder effect. Five markers were significantly enriched in patients compared to controls, and admixture analysis indicated a higher proportion of West Eurasian/European ancestry. Further systematic study is needed to identify the communities and regions where the SGCB p.Thr182Pro variant is observed in higher proportions.

Comprehensive laboratory diagnosis of Fanconi anaemia: comparison of cellular and molecular analysis

Journal of medical genetics, Vol. 60, Issue 8, Pages 801-809, 2023
PMID: 36894310
Fanconi anaemia (FA) is a rare inherited bone marrow failure disease caused by germline pathogenic variants in any of the 22 genes involved in the FA-DNA interstrand crosslink (ICL) repair pathway. Accurate laboratory investigations are required for FA diagnosis for the clinical management of the patients. We performed chromosome breakage analysis (CBA), FANCD2 ubiquitination (FANCD2-Ub) analysis and exome sequencing of 142 Indian patients with FA and evaluated the efficiencies of these methods in FA diagnosis.

True Fetal Trisomy 22 Detected Using Genome-Wide Noninvasive Prenatal Testing

Journal of obstetrics and gynaecology of India, Vol. 73, Issue 2, Pages 180-182, 2023
PMID: 37073230
Autosomal aneuploidies occurring in chromosomes other than 13, 18, and 21 and sex chromosomal aneuploidies are referred to as ‘Rare autosomal aneuploidies’ (RAAs). A prenatal incidence of 0.41% is noted for RAAs on chorionic villus sampling (CVS) procedures. Aneuploidies in autosomes other than 13, 18, and 21 and sex chromosomal aneuploidies may result in increased fetal-placental diseases such as non-viable pregnancy, early miscarriage, intrauterine fetal growth restriction, uniparental disomy, multiple congenital anomalies, fetal demise, or normal live birth [1].

Genotype-phenotype correlation and natural history study of dysferlinopathy: a single-centre experience from India

Neurogenetics, Vol. 24, Issue 1, Pages 43-53, 2022
PMID: 36580222
Dysferlinopathies are a group of limb-girdle muscular dystrophies causing significant disability in the young population. There is a need for studies on large cohorts to describe the clinical, genotypic and natural history in our subcontinent. To describe and correlate the clinical, genetic profile and natural history of genetically confirmed dysferlinopathies.

Near-chromosomal de novo assembly of Bengal tiger genome reveals genetic hallmarks of apex predation

GigaScience, Vol. 12, 2022
PMID: 36576130
The tiger, a poster child for conservation, remains an endangered apex predator. Continued survival and recovery will require a comprehensive understanding of genetic diversity and the use of such information for population management. A high-quality tiger genome assembly will be an important tool for conservation genetics, especially for the Indian tiger, the most abundant subspecies in the wild.

Metabolic and Genetic Evaluation in Children with Nephrolithiasis

Indian journal of pediatrics, Vol. 89, Issue 12, Pages 1243-1250, 2022
PMID: 35819704
To evaluate metabolic and genetic abnormalities in children with nephrolithiasis attending a referral center in North India.

A novel compound heterozygous BEST1 gene mutation in two siblings causing autosomal recessive bestrophinopathy

BMC ophthalmology, Vol. 22, Issue 1, Pages 493, 2022
PMID: 36527004
To describe the clinical features, imaging characteristics, and genetic test results associated with a novel compound heterozygous mutation of the BEST1 gene in two siblings with autosomal recessive bestrophinopathy.

Genome-Wide Polygenic Score Predicts Large Number of High Risk Individuals in Monogenic Undiagnosed Young Onset Parkinson’s Disease Patients from India

Advanced biology, Vol. 6, Issue 11, Pages e2101326, 2022
PMID: 35810474
Parkinson’s disease (PD) is a genetically heterogeneous neurodegenerative disease with poorly defined environmental influences. Genomic studies of PD patients have identified disease-relevant monogenic genes, rare variants of significance, and polygenic risk-associated variants.